This presentation, sponsored by Digestive Cancers Europe, provides an overview of the role of patient’s immune response in early colorectal cancer and the best approach for patients and doctors to jointly manage treatment at this stage for improved patient outcomes. Dr. Dhillon is a medical oncologist based at The Royal Surrey Hospital NHS in the UK.
Prognostic & Predictive value of the Immunoscore in Stage III Colon Cancer, Annals of Oncology 2020
For more information, please contact:
Veracyte Labs VA
737 N 5th St, Suite 600, Richmond, VA, 23219